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Considerations in the use of different
spirometers in epidemiological studies
Edith B. Milanzi1, Gerard H. Koppelman2,3, Marieke Oldenwening1, Sonja Augustijn4, Bernadette Aalders-de Ruijter5,
Martijn Farenhorst4, Judith M. Vonk3,6, Marjan Tewis1, Bert Brunekreef1,7 and Ulrike Gehring1*
Abstract
Background: Spirometric lung function measurements have been proven to be excellent objective markers of
respiratory morbidity. The use of different types of spirometers in epidemiological and clinical studies may present
systematically different results affecting interpretation and implication of results. We aimed to explore considerations in
the use of different spirometers in epidemiological studies by comparing forced expiratory volume in 1 s (FEV1) and
forced vital capacity (FVC) measurements between the Masterscreen pneumotachograph and EasyOne spirometers. We
also provide a correction equation for correcting systematic differences using regression calibration.
Methods: Forty-nine volunteers had lung function measured on two different spirometers in random order with at
least three attempts on each spirometer. Data were analysed using correlation plots, Bland and Altman plots and
formal paired
t-tests. We used regression calibration to provide a correction equation.
Results: The mean (SD) FEV1 and FVC was 3.78 (0.63) L and 4.78 (0.63) L for the Masterscreen pneumotachograph and
3.54 (0.60) L and 4.41 (0.83) L for the EasyOne spirometer. The mean FEV1 difference of 0.24 L and mean FVC difference
of 0.37 L between the spirometers (corresponding to 6.3 and 8.4% difference, respectively) were statistically significant
and consistent between younger (< 30 years) and older volunteers (> 30 years) and between males and females.
Regression calibration indicated that an increase of 1 L in the EasyOne measurements corresponded to an average
increase of 1.032 L in FEV1 and 1.005 L in FVC in the Masterscreen measurements.
Conclusion: Use of different types of spirometers may result in significant systematic differences in lung function
values. Epidemiological researchers need to be aware of these potential systematic differences and correct for them in
analyses using methods such as regression calibration.
Keywords: Calibration, Epidemiological studies, Lung function, Spirometry, Systematic difference
Background
Spirometry is a commonly used test of lung function, an
important tool in the diagnosis, and monitoring of
respiratory diseases and is frequently used in epidemio-
logical and clinical research [1]. Results of spirometry
tests depend on several factors including technical
factors such as the type of spirometer used, personal
factors such as a subject’s posture, and the cooperation
between the subject and the technician, which need to
be considered in clinical and epidemiological studies.
Despite potential differences between spirometers,
there may be compelling reasons to use different
spirometers in clinical and epidemiological research.
In large-scale multicentre studies for example, for ef-
ficiency reasons more than one spirometer of the
same type or different spirometers of different types
may be used in different centres. In follow-up studies,
there may be need to replace older spirometers by
newer spirometers.
Comparisons between different types of spirometers
as well as similar types of spirometers have been
performed in several studies [2–5]. Systematic differ-
ences between different types of spirometers have
been reported [2, 4]. Such differences can bias
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exposure-health relationships in studies where the use
of a specific spirometer is associated with exposure,
e.g. in multi-centre studies of effects of ambient air
pollution where different spirometers are used in dif-
ferent study regions with different levels of exposure.
Adjustment for type of spirometer is one possibility
to account for systematic differences between spirom-
eters. However, this may result in over-adjustment if
region is also an important determinant of exposure.
Methods such as regression calibration are more suit-
able in such situations, but require data on compar-
ability of devices [6].
In this study we compared FEV1 and FVC measure-
ments from two widely used spirometers - the Mastersc-
reen pneumotachograph and the EasyOne spirometer
that were simultaneously used in the Prevention and
Incidence of Asthma and Mite Allergy (PIAMA) birth
cohort study. We also investigated comparability be-
tween two EasyOne spirometers. We used the obtained
measurements to provide a correction equation to adjust
for differences between the spirometers in an epidemio-
logical study.
Methods
Comparison study design and study population
Two series of spirometry tests were performed in volun-
teers by trained research staff between April and May
2017. In the first test series that we consider to be our
main comparison performed at the University Medical
Centre Groningen, we compared the Masterscreen
pneumotachograph with an EasyOne spirometer (re-
ferred to here as EasyOne1). Two highly experienced
and trained technicians conducted spirometry measure-
ments in the first test series (one with the Masterscreen
pneumotachograph and one with the EasyOne1). We let
each technician use a different spirometer by design to
reflect a real-life multicentre research setting where
different spirometers are used in different centers by
different technicians. In the second series, one of the
technicians involved in the first test series performed the
tests at Utrecht University, and the EasyOne1 from the
first series was compared to a second EasyOne spirom-
eter of the same generation, referred to as EasyOne2
(both purchased in 2008). In both series, all volunteers
performed tests on both spirometers in random order
but in immediate succession to eliminate confounding
by individual characteristics. Forced expiratory volume
in 1 s (FEV1) and forced vital capacity (FVC) were
measured in sitting position, while wearing a nose clip.
Measurements that fulfilled the ATS/ERS criteria [1]
were included in the analysis (n = 45 for each of the
series). In addition, test results were included which
did not meet these criteria (difference between the
largest and next largest value ≤150 mL for FEV1 and
FVC), but which were obtained from otherwise tech-
nically acceptable flow-volume curves with the differ-
ence between the largest and next largest values for
FEV1 and FVC ≤ 200 mL, (n = 4 for each of the two
series) as in previous analyses [7]. Zero flow was
established before each measurement with both de-
vices. For each test series, the final study population
consisted of 49 volunteers. Information on ethnicity,
self-reported weight, height and age of volunteers was
also collected.
The PIAMA cohort
The PIAMA birth cohort is a Dutch population-based
study that started in 1996/97 with 3963 new-borns
and has been extensively described elsewhere [8].
Follow-ups were conducted at the child's age of 3
months, yearly until age 8, and then at ages 11, 14,
16 and 17 years. Medical examinations with measure-
ments of lung function including FEV1 and FVC and
anthropometric characteristics such as weight and
height were conducted at ages 8, 12 and 16. At age
16, lung function measurements were obtained in 721
participants. Both the Masterscreen pneumotacho-
graph (CareFusion, Yorba Linda, CA, USA) and Easy
One spirometers (NDD Medical Technologies, Inc.,
Switzerland) were used to measure FEV1 and FVC at
age 16 in two centres, Groningen and Utrecht re-
spectively. We applied the correction equation in the
current study to lung function data from the PIAMA
cohort measured at age 16.
Ethical approval of the current study was obtained
from medical ethical review board from University
Medical Center Groningen (ref no. M17.220613) and
all volunteers provided consent to participate.
Spirometers
We used two EasyOne spirometers (NDD Medical
Technologies, Inc., Switzerland) and the Jaeger Mas-
terscreen pneumotachograph spirometer (CareFusion,
Yorba Linda, CA, USA).
The Masterscreen pneumotachograph is one of the
most widely used pulmonary function systems. It
measures lung volumes indirectly with a pneumo-
tachograph using the pressure difference over a
small, fixed resistance, offered by a fine metal mesh
[9]. In brief, it measures the pressure drop when a
patient blows into the device. The pressure drop
divided by the resistance of the pneumotachograph
yields the flow, which can be transformed into a
volume by time integration [10]. It is sensitive to
temperature, humidity and atmospheric pressure of
surrounding air and therefore requires constant
calibration.
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The EasyOne spirometer is a handheld standalone
flow-sensing instrument that requires no calibration though
calibration can be checked with a syringe [11]. Unlike the
Masterscreen pneumotachograph, the EasyOne spirometer
incorporates an ultrasonic flow sensor to measure the flow
of air in and out of the patients’ lungs. Ultrasonic flow mea-
surements are independent of gas composition, pressure,
temperature, and humidity and therefore inaccuracy is re-
duced due to the mentioned factors [12].
Statistical analysis
Sample size calculations were performed based on a stand-
ard deviation (SD) for FEV1 of 0.5 L. With a significance
level of 0.05, 44 volunteers were required to detect a mean
difference of 0.3 L between the spirometers with 80% power.
Correlations and agreement between spirometry mea-
surements performed with the different spirometers
were assessed with scatterplots, Pearson correlation co-
efficients and Bland and Altman plots [13]. Significance
of differences between spirometers (within persons) was
tested with paired t-tests.
In the absence of a gold standard, we computed the per-
cent predicted FEV1 and FVC according to sex, age,
height, and ethnicity based on reference regression
equations developed by the Global Lung Function
Initiative (GLI) [14] to assess which of the two spirometers
most likely gives a better estimate of the lung function.
Table 1 Study population characteristics
Masterscreen vs EasyOne1 Overall (N = 49) Males (N = 15) Females(N = 34)
Age (years) – mean (SD) 30.2 (10.9) 29.2 (10.8) 30.8 (11.1)
Age≤ 30 years – N (%) 32 (65) 12 (66) 29 (67)
Ethnicity-N (%)
Caucasian 49 (100) 15 (100) 34 (100)
Weight (Kg) – mean (SD) 68.9 (11.3) 72.6 (11.9) 66.9 (10.6)
Height (m) – mean (SD) 1.74 (8.32) 1.81 (6.46) 1.70 (6.57)
FEV1Masterscreen (L) – mean (SD) 3.78 (0.63) 4.38 (0.62) 3.51(0.43)
FEV1EasyOne 1 – mean (SD) 3.54 (0.60) 4.11 (0.57) 3.29 (0.42)
FVC Masterscreen (L) – mean (SD) 4.78 (0.85) 5.77 (0.76) 4.35 (0.42)
FVCEasyOne1 (L) – mean (SD) 4.41 (0.83) 5.35 (0.74) 4.01 (0.44)
FEV1Masterscreen mean (SD) percent predicted 98.3 (11.1) 93.6 (10.5) 100.4 (10.8)
FEV1EasyOne1 mean (SD) percent predicted 92.3 (10.8) 87.9 (9.9) 94.2 (10.7)
FVC Masterscreen mean (SD) percent predicted 103.7 (10.5) 101.2 (11.4) 104 (10.1)
FVC EasyOne1 mean (SD) percent predicted 95.5 (10.5) 93.8 (12.2) 96.2 (9.87)
EasyOne1 vs EasyOne2 Overall (N = 49) Males (N = 17) Females (N = 32)
Age (years) - mean (SD) 35.1 (11.4) 32.8 (10.4) 37.4 (12.1)
Age≤ 30 years – N (%) 23 (46) 11 (47) 12 (52)
Ethnicity- N (%)
Caucasian 43 (88) 15 (88) 28 (88)
Asian 4 (8) 2 (12) 2 (6)
Other 2 (4) 0 (0) 2 (6)
Weight (Kg) – mean (SD) 68.1 (10.1) 76.1 (9.3) 63.7 (7.7)
Height (m) – mean (SD) 1.71 (0.11) 1.82 (0.72) 1.65 (0.86)
FEV1EasyOne 1(L) – mean (SD) 3.50 (0.85) 4.33 (0.63) 3.05 (0.58)
FEV1EasyOne 2 (L) – mean (SD) 3.46 (0.84) 4.27 (0.62) 3.03 (0.58)
FVCEasyOne1(L) – mean (SD) 4.31 (1.05) 5.45 (0.64) 3.71 (0.65)
FVCEasyOne2 (L) – mean (SD) 4.27 (1.04) 5.38 (0.65) 3.68 (0.66)
FEV1 EasyOne1 mean (SD) percent predicted 95.8 (11.1) 92.8 (12.2) 97.4 (10.2)
FEV1 EasyOne2 mean (SD) percent predicted 94.8 (11.2) 91.5 (12.1) 96.5 (10.5)
FVCEasyOne1mean (SD) percent predicted 97.4 (9.9) 96.1 (11.1) 98.1 (9.3)
FVCEasyOne2mean (SD) percent predicted 96.5 (10.2) 94.8 (11.1) 97.4 (9.7)
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Moreover, we used the data from the first test series to
provide a correction equation by regressing measurements
from the Masterscreen pneumotachograph on the
measurements obtained by the EasyOne1 spirometer as
follows:
FEV 1Masterscreen ¼ αþ βFEV 1EasyOne1
FVCMasterscreen ¼ αþ βFVCEasyOne1
The regression coefficients can be used to correct for
systematic differences in epidemiological analyses and
we showed this by applying the equation to lung func-
tion data from the PIAMA birth cohort collected at age
16. Data were analysed using SAS version 9.4 (The SAS
Institute, Cary, NC, USA).
Results
Table 1 shows characteristics of the volunteers that
participated in the two series of spirometer comparisons.
On average, the FEV1 and FVC as measured by the
Masterscreen pneumotachograph were significantly
higher than the FEV1 and FVC as measured by the
EasyOne1 spirometer (FEV1: 3.78 L vs 3.54 L, mean
difference 0.24 L, p-value < 0.0001; FVC: 4.78 L vs 4.41 L,
mean difference 0.37 L, p-value < 0.0001). The 0.24 L
and 0.37 L mean differences, correspond to a 6.3%
decrease in FEV1 switching from the Masterscreen
pneumotachograph to the EasyOne1 spirometer and
8.4% decrease in FVC switching from the Masterscreen
pneumotachograph to the EasyOne1 spirometer respect-
ively. Differences in FEV1 and FVC between the two
EasyOne spirometers were small i.e. FEV1: 3.50 L vs 3.46
L with a mean difference of 0.03 L, p-value < 0.003 and
FVC: 4.31 L vs 4.27 L mean difference, 0.04 L, p-value
< 0.003, respectively. The mean differences correspond
to a 1.1% decrease in FEV1 switching from the Easy-
One1 to the EasyOne2 spirometer and 0.9% decrease
in FVC switching from the EasyOne1 to the Easy-
One2 spirometer (Tables 1 and 2). The observed
differences between the spirometers were similar in
males and females and in younger and older volun-
teers (Table 2).
Measurements were highly correlated (r = 0.98 for the
first test series and r = 0.99 for the second test series for
both FEV1 and FVC) indicating a strong linear relation-
ship, which deviates from identity (Fig. 1) for FEV1 (but
not FVC) in the first test series, but not for the second
test series. The Bland and Altman plots show that the
mean differences are consistently larger than zero indicat-
ing a systematic difference between the two spirometers
with the Masterscreen pneumotachograph consistently
producing higher values than the EasyOne1. There was no
systematic difference between the two EasyOne1 and
EasyOne2 measurements (Fig. 2).
Using the GLI reference equations, the percent
predicted for the Masterscreen pneumotachograph was
close to 100% (98.3% for FEV1 and 103.7% for FVC), but
less so for the EasyOne1 (92.3% for FEV1 and 95.5% for
FVC).
Regression of the measurements from the Masterscreen
pneumotachograph on the EasyOne1 measurements pro-
duced the following regression equations (Fig. 1):
FEV1Masterscreen ¼ 0:114 0:05ð Þ
þ1:032 0:01ð Þ  FEV1EasyOne1
FVCMasterscreen ¼ 0:357 0:05ð Þ
þ1:005 0:01ð Þ  FVCEasyOne1
The above regression equations indicate that an in-
crease of 1 L in the EasyOne1 measurements is associ-
ated with an estimated average increase of 1.032 L for
the FEV1 and 1.005 L for the FVC in the Masterscreen
pneumotachograph measurements.
Table 3 shows the mean of FEV1 and FVC as mea-
sured in the PIAMA birth cohort at the age of 16 years,
before and after correction for the systematic differ-
ences. The mean difference reduces from 0.37 L to 0.13
L for FEV1 and 0.44 L to 0.07 L for FVC after correction.
Discussion
We compared FEV1 and FVC measurements from two
different, widely used spirometers, the EasyOne and
Masterscreen pneumotachograph and found that the
EasyOne spirometer provided on average systematically
lower measurements than the Masterscreen. We also
investigated the agreement between two EasyOne
spirometers of the same generation and found that
Table 2 Mean differences (with confidence intervals):
Masterscreen vs EasyOne1 and EasyOne1 vs EasyOne2, overall
and by age and sex
FEV1 (L) FVC (L)
N Mean diff. 95% CI Mean diff. 95% CI
Masterscreen –EasyOne1
Overall 49 0.24 (0.19;0.26) 0.37 (0.33; 0.41)
≤ 30 years 32 0.23 (0.18; 0.27) 0.37 (0.31; 0.42)
> 30 years 17 0.23 (0.17; 0.29) 0.38 (0.33; 0.44)
Males 15 0.26 (0.18; 0.35) 0.42 (0.31; 0.53)
Females 34 0.21 (0.18; 0.24) 0.35 (0.31; 0.39)
EasyOne1 –EasyOne2
Overall 49 0.03 (0.01;0.06) 0.04 (0.01; 0.06)
≤ 30 years 23 0.03 (−0.00; 0.08) 0.04 (0.00; 0.08)
> 30 years 26 0.03 (0.00; 0.06) 0.03 (−0.00; 0.07)
Males 17 0.06 (0.00; 0.11) 0.06 (0.01; 0.12)
Females 32 0.02 (0.00; 0.05) 0.02 (− 0.00;0.05)
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measurements were comparable, but with a small signifi-
cant difference.
In epidemiological studies, lung function measure-
ments can be performed using more than one spirom-
eter of the same type or different types. This study
showed a systematic difference between two types of spi-
rometers used in the PIAMA birth cohort study [15].
We conducted this experiment in healthy volunteers for
which the mean percent predicted FEV1 and FVC was
expected to be close to 100%. Based on reference equa-
tions provided by the GLI [14], for none of the spirome-
ters the mean percent FEV1 and FVC was exactly 100%,
but percentages were closer to 100% for the Mastersc-
reen pneumotachograph than the EasyOne1 especially
for FEV1. The lower percent predicted lung function for
the EasyOne1 suggests that the EasyOne spirometer may
be more likely to overestimate the percentage of subjects
with a clinically low lung function in a setting where
different spirometers are used. This has been previously
demonstrated in a comparison involving the EasyOne
spirometer and a water-sealed spirometer (Collins,
Stead-Wells) where underestimated values of both FEV1
and FVC from the EasyOne spirometer and conse-
quently higher prevalence rates of airway obstruction
were observed [16]. It is important to note that the GLI
reference equations are not universally applicable.
However, these equations are based on an extensive
database and studies in the Netherlands have shown that
Fig. 1 Correlation between measurements from the first comparison series (Masterscreen and EasyOne1 spirometer, upper panels) and the
second series (EasyOne1 spirometer from the first series and another EasyOne2 spirometer of the same generation, lower panel)
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Fig. 2 Bland and Altman plots of FEV1 and FVC measurements from the first test series (Masterscreen and EasyOne1 spirometer, upper panels)
and the second test series (EasyOne1 spirometer from the first series and another EasyOne2 spirometer of the same generation, lower panel)
Table 3 Means of corrected lung function measurements from PIAMA lung function data
Uncorrected Mean (95% CI) Corrected Mean (95% CI)
Overall FEV1 (L) 3.81 (3.75; 3.86) 3.94 (3.89; 4.00)
FEV1_EasyOne1 (L) 3.65 (3.58; 3.72) 3.88 (3.81; 3.95)
FEV1_Masterscreen (L) 4.03 (3.95; 4.11) 4.03 (3.95; 4.11)
Mean difference (L) −0.37 (− 0.47; − 0.26) −0.13 (− 0.24; − 0.03)
Overall FVC (L) 4.48 (4.42; 4.55) 4.70 (4.64; 4.77)
FVC_EasyOne1 (L) 4.30 (4.21; 4.38) 4.67 (4.59;4.76)
FVC_Masterscreen (L) 4.74 (4.64; 4.84) 4.74 (4.64; 4.84)
Mean difference (L) −0.44 (− 0.56; − 0.31) −0.07 (− 0.19; 0.07)
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measurements in the Dutch population generally agree
with the GLI references values in adults [17]. We there-
fore believe these equations are most likely suitable for
our current study population as the Masterscreen-Easy-
One comparison population was 100% Dutch. It is ad-
vised that regardless of which reference equations are
used, clinical decisions should never be based solely on
lung function test results but backed up with comple-
mentary laboratory clinical and physical findings [18].
Several studies have conducted similar experiments com-
paring different types of spirometers, handheld/office and
standard laboratory spirometers both in clinical and re-
search settings [2–4, 19–22], with the comparisons also
used as quality control procedure in international multicen-
tre epidemiological studies [23, 24]. High correlations were
observed throughout these studies, but significant system-
atic differences between spirometers in some of the studies
[2, 19, 20] suggest that measurements from different spi-
rometers are not always comparable. Kunzli et al. [4] con-
ducted a study comparing eight flow sensing spirometers of
the same type (Sensormedics 2200) and found that the new
generation of Sensormedics (Vmax) gave systematically
lower results than the older generation. Based on this com-
parison, an informed decision on choice of spirometers to
use for their follow up study was made by excluding the
new generation spirometers in the SALPADIA cohort.
Similar practical changes were made in another study based
on a similar comparison [23]. Small systematically lower
FVC and FEV1 at follow-up, may eventually translate into
erroneous deficits of lung function in the studied popula-
tion, leading to erroneous conclusions about the effect of
environmental, biologic or life-style factors on lung func-
tion changes [2]. Use of different types of lung function spi-
rometers in the same study can be less detrimental if
comparability is established and if necessary any systematic
differences corrected.
The source of the observed differences between the Mas-
terscreen pneumotachograph and the EasyOne spirometer
is unclear. The Masterscreen pneumotachograph was rou-
tinely calibrated for each session as per requirement. The
EasyOne spirometers are made to require no calibration
but were occasionally checked using a calibration syringe.
Both spirometers were therefore thoroughly checked as
regards calibration such that chances that the observed dif-
ferences are due to calibration differences are minimal.
However, the following limitations should be considered:
two experienced technicians performed the first test series
(one with the Masterscreen pneumotachograph and one
with the EasyOne) and one of them performed all measure-
ments of the second test series. We designed the compari-
son of the Masterscreen pneumotachograph and EasyOne
spirometers such that different technicians operated the dif-
ferent spirometers to imitate a real multicentre study.
While the technicians were highly trained and experienced,
due to the study design it was impossible to disentangle dif-
ferences between spirometers from differences between
technicians. Consequently, part of the observed difference
between spirometers may be attributable to differences be-
tween technicians. The provided correction equation thus
simultaneously corrects for the technician and device effect
and may not be generalizable to other studies where differ-
ent technicians are involved. However, it is expected that
the calibration method can be applied accordingly. We
were not able to assess the external validity of the correc-
tion for spirometry measurements outside the PIAMA
population, but it has been used before to correct spirom-
etry measurements [6] and the method has been validated
in other fields of epidemiology [25]. We used self-reported
instead of measured height and weight for the in total 98
volunteers that participated in the comparisons of the spi-
rometers. Since spirometers were compared within per-
sons, and consequently height and weight did not differ
between the spirometers that were compared within a
series, this does not affect the observed differences be-
tween spirometers. Self-reported height might be a source
of bias when applying the GLI equations as height values
may be over−/underreported. Weight is not used in the
GLI equations to estimate percent predicted lung function
and therefore poses no risk of bias. Studies of the agree-
ment between self-reported and measured weight and
height provided inconsistent results, some suggested good
agreement [26, 27], while others reported significant dis-
crepancies mainly in overweight/obese individuals [28,
29]. It is also not clear to what extent the systematic differ-
ences between the two spirometers can be attributed to
hardware as computer software has been identified as an-
other as major source of discrepancies between spirome-
ters [30].
The strength of this study is that the order of the
spirometers was randomized to minimize influences of
personal characteristics and differences due to study
design. We observed high precision of the regression
parameter estimates, which highly suggests that the
sample size in our experiment is not a concern.
Conclusion
We observed systematic differences between lung function
measurements from two spirometers of different types.
Epidemiological researchers need to be aware of these po-
tential systematic differences and correct for them in the
analyses using methods such as regression calibration.
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